| |
| Issue |
Title |
| |
| Vol 17, No 4 (2024) |
Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, I. Z. Gaydukova |
| |
| Vol 17, No 4 (2024) |
Development of a classification of anesthetic management methods and protocols for calculating financial costs |
Abstract
PDF (Rus)
|
|
D. V. Lukyantseva, J. A. Agafonova, V. V. Omelyanovskiy, S. A. Kovaleva, D. V. Fedyaev, I. N. Pasechnik, V. V. Schukin, D. S. Blinov, A. B. Abrosimov |
| |
| Vol 17, No 4 (2024) |
Scenario modeling of the drug prescription process for children: application of machine learning methods |
Abstract
PDF (Rus)
|
|
А. А. Kondrashov, М. М. Kurashov, Е. Е. Loskutova |
| |
| Vol 17, No 4 (2024) |
Regional aspects of availability of expectorants and antitussive drugs |
Abstract
PDF (Rus)
|
|
V. М. Timiryanova, А. V. Samorodov, Z. А. Valiullina, V. B. Prudnikov, D. Kh. Krasnoselskaya |
| |
| Vol 17, No 3 (2024) |
Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, V. A. Ryagina, A. G. Kharitonova, K. I. Matrenin, A. A. Kingshott, O. V. Ashikhmina, M. V. Zhirov |
| |
| Vol 17, No 3 (2024) |
Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences |
Abstract
PDF (Rus)
|
|
E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov |
| |
| Vol 17, No 3 (2024) |
Approaches to developing mechanisms for medical care centralization at the interterritorial level |
Abstract
PDF (Rus)
|
|
D. V. Fedyaev, F. S. Nikitin, S. A. Kovaleva, V. V. Omelyanovskiy |
| |
| Vol 17, No 3 (2024) |
Differential chemoproteomic analysis of RRS-1 candidate molecule and molecules of several nonsteroidal anti-inflammatory drugs |
Abstract
PDF (Rus)
|
|
P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, K. F. Suzdalev, R. A. Murashko, A. V. Zelenskaya, A. V. Zadorozhniy, T. R. Glechyan, G. V. Simavonyan, E.M. I. Muhammad |
| |
| Vol 17, No 3 (2024) |
The influence of the combination of methanolic extract Scurrula atropurpurea (Blume) and Dendrophthoe pentandra on rat liver function and structure |
Abstract
PDF (Eng)
|
|
N. Athiroh, N. J. Mubarakati, Yu. Purnomo |
| |
| Vol 17, No 2 (2024) |
Clinical and economic assessment of using IRS®19 for the treatment and prevention of acute respiratory infections in children |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, A. R. Kasimova |
| |
| Vol 17, No 2 (2024) |
Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access |
Abstract
PDF (Rus)
|
|
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy |
| |
| Vol 17, No 2 (2024) |
Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, I. N. Dyakov |
| |
| Vol 17, No 2 (2024) |
Chemoreactomic study of fonturacetam effects: molecular mechanisms of influence on adipose tissue metabolism |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin |
| |
| Vol 17, No 2 (2024) |
Clinical and economic assessment of using topical bacterial lysate Imudon® for the treatment and prevention of acute upper respiratory tract infections in children |
Abstract
PDF (Rus)
|
|
A. R. Kasimova, A. S. Kolbin |
| |
| Vol 17, No 2 (2024) |
The effectiveness of rehabilitation in vulvovaginal atrophy |
Abstract
PDF (Rus)
|
|
D. М. Ampilogova, А. G. Solopova, D. V. Blinov, А. Е. Ivanov, S. V. Khlopkova, G. К. Bykovshchenko |
| |
| Vol 17, No 2 (2024) |
Mathematical modeling and analysis of export trends for certain pharmaceutical groups |
Abstract
PDF (Rus)
|
|
А. R. Shaikhislamova, N. А. Gasratova |
| |
| Vol 17, No 3 (2024) |
Chemoreactomic analysis of the antioxidant properties of vitamin B12 derivatives |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, L. A. Maiorova |
| |
| Vol 17, No 2 (2024) |
Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology |
Abstract
PDF (Rus)
|
|
А. N. Rubashkina, I. Yu. Torshin, O. A. Gromova, A. N. Galustyan |
| |
| Vol 17, No 2 (2024) |
Study of lithium carbonate and ascorbate proliferative properties on transplantable Lewis lung carcinoma metastasis model |
Abstract
PDF (Rus)
|
|
D. E. Frolova, I. Yu. Torshin, V. V. Rastashansky, M. V. Filimonova, O. A. Gromova |
| |
| Vol 17, No 1 (2024) |
Chemoreactome screening of aquacobalamin and heptamethyl ester of cyanoaquacobyrinic acid cytotoxic effects on tumor cells with experimental confirmation on BT-474 and A549 cell |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, M. V. Filimonova, O. A. Gromova, L. A. Maiorova, M. A. Sorokina, D. E. Frolova, A. N. Gromov, I. A. Reyer |
| |
| Vol 17, No 1 (2024) |
STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia |
Abstract
PDF (Rus)
|
|
A. V. Zhuravlev, O. I. Knysh |
| |
| Vol 17, No 1 (2024) |
Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov |
| |
| Vol 17, No 1 (2024) |
Chemoreactomic analysis of acyzole in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs |
Abstract
PDF (Rus)
|
|
P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, R. A. Murashko, A. V. Zelenskaya, L. O. Alukhanyan, O. V. Shelemekh |
| |
| Vol 17, No 1 (2024) |
Clinical and economic implications of using daratumubab with lenalidomide in the 1st and 2nd lines of therapy for multiple myeloma patients |
Abstract
PDF (Rus)
|
|
О. I. Ivakhnenko, V. V. Ryazhenov, N. A. Falaleeva |
| |
| Vol 17, No 1 (2024) |
Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
S. К. Zyryanov, I. N. Dyakov |
| |
| Vol 17, No 1 (2024) |
Changes in patient recruitment parameters and their derivatives under the influence of external factors – population size and density of residence in a certain area |
Abstract
PDF (Rus)
|
|
S. S. Milovanov |
| |
| Vol 17, No 1 (2024) |
Assessing the awareness of doctors of various specialties in the treatment of osteoporosis |
Abstract
PDF (Rus)
|
|
V. A. Alekseeva, A. V. Krikova, Т. Yu. Filatova, E. V. Dmitrieva, A. V. Ovsyankin, E. S. Kuzminova |
| |
| Online First |
Antitumor effects of vitamin B12 in vitro, in vivo, in silico |
Abstract
PDF (Rus)
|
|
O. A. Gromova, D. E. Frolova, I. Yu. Torshin, M. V. Filimonova, M. A. Sorokina, I. A. Reyer, O. A. Limanova, L. E. Fedotova, L. A. Maiorova |
| |
| Vol 17, No 3 (2024) |
Chemoproteomic analysis of the pharmacological properties of vitamin В12 derivatives |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova |
| |
| Vol 16, No 4 (2023) |
Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova |
| |
| Vol 16, No 4 (2023) |
Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, K. V. Orlova |
| |
| Vol 16, No 4 (2023) |
Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis |
Abstract
PDF (Rus)
|
|
A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva |
| |
| Vol 16, No 4 (2023) |
Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer |
Abstract
PDF (Rus)
|
|
E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko |
| |
| Vol 16, No 4 (2023) |
Socio-economic burden of respiratory syncytial viral infection of the lower respiratory tract in children aged from birth to 5 years in the Russian Federation: modeling results |
Abstract
PDF (Rus)
|
|
V. I. Ignatyeva, D. Yu. Ovsyannikov, A. E. Tsygankov, E. E. Yagnenkova, V. R. Amirova, M. M. Maryanyan, A. S. Mokrova |
| |
| Vol 16, No 4 (2023) |
Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova |
| |
| Vol 16, No 4 (2023) |
Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova |
| |
| Vol 16, No 4 (2023) |
Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development |
Abstract
PDF (Rus)
PDF (Eng)
|
|
V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan |
| |
| Vol 16, No 4 (2023) |
Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market |
Abstract
PDF (Rus)
|
|
I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova |
| |
| Vol 16, No 3 (2023) |
Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina |
| |
| Vol 16, No 3 (2023) |
Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, I. N. Dyakov |
| |
| Vol 16, No 3 (2023) |
The role of ferritin in liver disease assessment |
Abstract
PDF (Rus)
|
|
V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik |
| |
| Vol 16, No 3 (2023) |
An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis |
Abstract
PDF (Rus)
|
|
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova |
| |
| Vol 16, No 3 (2023) |
Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia |
Abstract
PDF (Rus)
|
|
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva |
| |
| Vol 16, No 3 (2023) |
Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation |
Abstract
PDF (Rus)
|
|
D. V. Fedyaev, F. S. Nikitin, T. N. Artamonova, S. A. Kovaleva, V. V. Omelyanovskiy |
| |
| Vol 16, No 3 (2023) |
Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia |
Abstract
PDF (Rus)
|
|
N. A. Avxentyev, Yu. V. Makarova |
| |
| Vol 16, No 3 (2023) |
Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region |
Abstract
PDF (Rus)
|
|
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin |
| |
| Vol 16, No 3 (2023) |
Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer |
Abstract
PDF (Rus)
|
|
I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova |
| |
| Vol 16, No 4 (2023) |
Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C |
Abstract
PDF (Rus)
|
|
I. A. Narkevich, E. A. Tsitlionok |
| |
| Vol 16, No 4 (2023) |
Comparative chemomicrobiomic analysis of bacteriocins |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova |
| |
| Vol 16, No 2 (2023) |
Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina |
| |
| 51 - 100 of 199 Items |
<< < 1 2 3 4 > >>
|
